This trial is testing whether two drugs, given together, are more effective than either drug given alone, for treating melanoma that has spread or can't be removed by surgery.
1 Primary · 5 Secondary · Reporting Duration: baseline and before each cycle (every 4 weeks) of nivolumab for a period of 12 months
37 Total Participants · 1 Treatment Group
Primary Treatment: Nivolumab · No Placebo Group · Phase 2
Age 18+ · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: